534 filings
Page 7 of 27
6-K
NVCN
Neovasc Inc
17 Dec 20
Neovasc Announces Publication of Peer-Reviewed Article in EuroIntervention
7:04am
EFFECT
NVCN
Neovasc Inc
17 Dec 20
Notice of effectiveness
12:15am
6-K
NVCN
Neovasc Inc
15 Dec 20
Neovasc Announces First Neovasc Reducerâ„¢ Implants in France
7:02am
6-K
NVCN
Neovasc Inc
15 Dec 20
Securities Purchase Agreement
12:00am
6-K
NVCN
Neovasc Inc
14 Dec 20
Neovasc Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
9:16pm
F-X
NVCN
Neovasc Inc
14 Dec 20
Appointment of agent for service of process by issuers registering securities
4:37pm
F-10
NVCN
Neovasc Inc
14 Dec 20
Registration of securities (Canada)
4:19pm
6-K
NVCN
Neovasc Inc
11 Dec 20
Neovasc Receives Nasdaq Notification Regarding Minimum Market Value Deficiency
6:12am
6-K
NVCN
Neovasc Inc
10 Dec 20
Current report (foreign)
5:23pm
6-K
NVCN
Neovasc Inc
10 Dec 20
Neovasc Announces Closing of US$6.1 Million Registered Direct Offering Priced At-the-Market
4:51pm
424B5
NVCN
Neovasc Inc
8 Dec 20
Prospectus supplement for primary offering
9:09pm
6-K
NVCN
Neovasc Inc
8 Dec 20
Neovasc Announces US$6.1 Million Registered Direct Offering Priced At-the-Market
11:17am
6-K
NVCN
Neovasc Inc
1 Dec 20
Neovasc Announces Participation in Noble Capital Markets Virtual Road Show Series
4:36pm
6-K
NVCN
Neovasc Inc
17 Nov 20
Neovasc to Participate in Canaccord Genuity 2020 Virtual MedTech & Diagnostics Forum
12:00am
6-K
NVCN
Neovasc Inc
5 Nov 20
Neovasc Announces Third Quarter Financial Results
4:10pm
6-K
NVCN
Neovasc Inc
5 Nov 20
Condensed Interim Consolidated Financial Statements
4:09pm
6-K
NVCN
Neovasc Inc
28 Oct 20
Neovasc Announces FDA Advisory Panel Result on Neovasc Reducerâ„¢ Medical Device for the Treatment of Refractory Angina
2:11pm
6-K
NVCN
Neovasc Inc
22 Oct 20
Current report (foreign)
9:00am
6-K
NVCN
Neovasc Inc
13 Oct 20
Current report (foreign)
8:03am
6-K
NVCN
Neovasc Inc
25 Sep 20
Current report (foreign)
6:03am